)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Orthocell
Orthocell (OCC) investor relations material
Orthocell H2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2026 earnings summary30 Aug, 2026
Executive summary
Achieved record revenue of A$13.2M for FY26, up 45% year-over-year, driven by increased adoption of collagen medical devices in established and new international markets.
Expanded US commercial footprint for Remplir, with 18 distributors across 20+ states, 70 hospitals purchasing, and 76 surgeons using the product.
Strengthened financial position with A$44M in available funds and completed a A$30M capital raise.
Advanced manufacturing expansion and automation to support future growth.
Financial highlights
Revenue grew to A$13.2M from A$9.1M in FY25 (+45%).
Gross profit increased to A$6.7M from A$3.6M (+86%).
Loss after income tax widened to A$13.9M from A$8.6M (+62%).
Net tangible assets per share rose to A$0.1235 from A$0.0555.
No dividends declared or paid.
Outlook and guidance
Focus on deepening US market adoption for Remplir and expanding in established and new international markets.
Continued investment in manufacturing, regulatory, and product development initiatives.
Anticipates further revenue growth as market access converts to routine clinical use.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Orthocell
- FY24 revenue up 31%, global expansion of Striate+ and Remplir, strong cash, no debt.OCC
Company presentation - FDA-cleared Remplir targets the $1.6B US nerve repair market with strong clinical and financial backing.OCCInvestor presentation
- US sales ramp up, breakeven in sight, and global expansion supported by strong funding.OCCInvestor presentation
- Record revenue growth and strong liquidity support ongoing global expansion.OCCQ4 2026 TU
- Record revenue growth and global expansion driven by innovative collagen medical devices.OCCAGM 2024 presentation
- First US surgical use achieved, with sales ramp-up and strong clinical results supporting growth.OCCInvestor presentation
- US Remplir launch accelerates revenue growth, with robust pipeline and global expansion plans.OCCAGM 2025 presentation
- Rapid US adoption and global expansion of Remplir drive strong growth and new market opportunities.OCCInvestor presentation
- 48% revenue growth and global expansion offset by higher net loss; strong cash supports growth.OCCH1 2026
Orthocell
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage